Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Hungerer

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Pharmaceutical Research|July 10, 2001
Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in miceT Jung, W Kamm, A Breitenbach, et al.
Human Antibodies and Hybridomas|January 1, 1994
A human monoclonal antibody with the capacity to neutralize Staphylococcus aureus alpha-toxinN Heveker, A Hansen, K D Hungerer, et al.
Biochimica Et Biophysica Acta|August 4, 1993
Effects of monoclonal antibodies on alpha-staphylotoxin action against erythrocytes and model phospholipid membranesO V Krasilnikov, V I Ternovsky, P G Merzliak, et al.
Medical Microbiology and Immunology|March 1, 1993
In vivo effects of intravascularly applied Escherichia coli hemolysin: dissociation between induction of granulocytopenia and lethality in monkeysD Vagts, H P Dienes, P J Barth, et al.
Behring Institute Mitteilungen|February 1, 1997
The Pseudomonas aeruginosa outer membrane protein I vaccine: immunogenicity and safe administration in manB U von Specht, H C Lücking, B Blum, et al.
Vaccine|August 1, 1996
Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteersB U von Specht, H C Lücking, B Blum, et al.
Circulation|August 22, 2001
Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic dietH A Lehr, T A Sagban, C Ihling, et al.
Infection and Immunity|April 1, 1991
Protection of immunosuppressed mice against infection with Pseudomonas aeruginosa by recombinant P. aeruginosa lipoprotein I and lipoprotein I-specific monoclonal antibodiesM Finke, G Muth, T Reichhelm, et al.
Vaccine|April 9, 1999
A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosaB Knapp, E Hundt, U Lenz, et al.
Behring Institute Mitteilungen|December 1, 1994
Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidatesB U von Specht, H Domdey, F Schödel, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Pharmaceutical Research|July 10, 2001
Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in miceT Jung, W Kamm, A Breitenbach, et al.
Human Antibodies and Hybridomas|January 1, 1994
A human monoclonal antibody with the capacity to neutralize Staphylococcus aureus alpha-toxinN Heveker, A Hansen, K D Hungerer, et al.
Biochimica Et Biophysica Acta|August 4, 1993
Effects of monoclonal antibodies on alpha-staphylotoxin action against erythrocytes and model phospholipid membranesO V Krasilnikov, V I Ternovsky, P G Merzliak, et al.
Medical Microbiology and Immunology|March 1, 1993
In vivo effects of intravascularly applied Escherichia coli hemolysin: dissociation between induction of granulocytopenia and lethality in monkeysD Vagts, H P Dienes, P J Barth, et al.
Behring Institute Mitteilungen|February 1, 1997
The Pseudomonas aeruginosa outer membrane protein I vaccine: immunogenicity and safe administration in manB U von Specht, H C Lücking, B Blum, et al.
Vaccine|August 1, 1996
Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteersB U von Specht, H C Lücking, B Blum, et al.
Circulation|August 22, 2001
Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic dietH A Lehr, T A Sagban, C Ihling, et al.
Infection and Immunity|April 1, 1991
Protection of immunosuppressed mice against infection with Pseudomonas aeruginosa by recombinant P. aeruginosa lipoprotein I and lipoprotein I-specific monoclonal antibodiesM Finke, G Muth, T Reichhelm, et al.
Vaccine|April 9, 1999
A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosaB Knapp, E Hundt, U Lenz, et al.
Behring Institute Mitteilungen|December 1, 1994
Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidatesB U von Specht, H Domdey, F Schödel, et al.
Pageof 3